Glen Hanson to Receive the 2016 IADR Distinguished Scientist Award in Pharmacology/Therapeutics/Toxicology Research
FOR IMMEDIATE RELEASE
IADR contact: Ingrid L. Thomas
+1.703.548.0066 or firstname.lastname@example.org
June 21, 2016
Alexandria, Va., USA - The International Association for Dental Research (IADR) will present Glen Hanson with the 2016 IADR Distinguished Scientist Award in Pharmacology/Therapeutics/Toxicology Research. He will be recognized at the Opening Ceremonies of the 94th IADR General Session & Exhibition, Wednesday, June 22, 2016, in Seoul, Republic of Korea. This meeting will be held in conjunction with the 3rd Meeting of the IADR Asia Pacific Region and the 35th Annual Meeting of the IADR Korean Division.
Hanson is currently a tenured professor in the University of Utah, Salt Lake City, USA, School of Dentistry and in the Department of Pharmacology & Toxicology in the College of Pharmacy. Serving as the senior associate dean for the newly founded University of Utah School of Dentistry, he is helping to develop a strong and sustainable infrastructure for research and scholarship within the D.D.S. program. He also currently serves as the director of the Utah Addiction Center at the University of Utah.
Hanson completed his undergraduate studies at Brigham Young University, Provo, Utah, USA. He completed his graduate studies at the University of California, Los Angeles (UCLA), USA, College of Dentistry and the University of Utah, Department of Pharmacology, College of Medicine. He did a postdoctoral fellowship at the National Institutes of Health (NIH) National Heart, Lung and Blood Institute and was an NIH Postdoctoral Research Associate (PRAT) Program fellow. He earned his D.D.S. from UCLA and his Ph.D. from the University of Utah.
He has testified multiple times before the United States Congress and the State of Utah Legislature on issues of drug abuse policy and is frequently interviewed by local and international media about these topics. Hanson is a member of the State of Utah Legislative Advisory Committee on Drugs of Abuse, has authored more than 200 peer-reviewed scientific papers and has been awarded more than $30 million in grants to conduct research related to drug abuse and its treatment. He also is the senior author for a leading college textbook on drug abuse titled “Drugs and Society.”
The Pharmacology/Therapeutics/Toxicology Research Award is one of the 17 IADR Distinguished Scientist Awards and is one of the highest honors bestowed by IADR. The Award is made for outstanding and sustained peer-reviewed research that has contributed to our knowledge of the mechanisms, efficacy, or safety of drugs used in dentistry and consists of a monetary prize and a plaque.
About the International and American Associations for Dental Research
The International Association for Dental Research (IADR) is a nonprofit organization with nearly 10,500 individual members worldwide, dedicated to: (1) advancing research and increasing knowledge for the improvement of oral health worldwide, (2) supporting and representing the oral health research community, and (3) facilitating the communication and application of research findings. To learn more, visit www.iadr.org.